BNP7787

· BioNumerik Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNP7787, covering 2022-07-13 to 2022-07-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel [Phase 3]

See pricing